Atherosclerosis Cardiovascular Disease Clinical Trials

18 clinical trials for Atherosclerosis Cardiovascular Disease across international registries, including 9 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes) — RECRUITING · PHASE3
• Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension — RECRUITING · NA
• Evaluation of the Association Between the Effects of Generalized Stage 3 and 4 Periodontitis on Arterial Stiffness and Cardiovascular Risk: the PAROCAR Study — RECRUITING · NA
• Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis — RECRUITING · PHASE2
• Oral Microbiome in Carotid Atherosclerosis — RECRUITING
• Deciphering the Effect of Moderate Wine Consumption on Healthy Aging Through Postprandial Extracellular Vesicles. — RECRUITING · NA
• Evaluating Atherosclerotic Disease Progression in Patients With Diabetes Mellitus — RECRUITING
• [18F]AlF-NOTA-octreotide PET/MRI in Carotid Artery Disease — RECRUITING · PHASE2
• The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease — RECRUITING · PHASE4
• Effects of Icosapent Ethyl on Coronary Plaque, Inflammation, and Ventricular Remodeling — NOT_YET_RECRUITING
• Associations Between Dietary Patterns, LDL Aggregation, and Cardiometabolic Health: A Cross-sectional Analysis. — NOT_YET_RECRUITING
• Comparative Effects of Carnivore and Mediterranean-style Diets on LDL Aggregation and Cardiometabolic Health — NOT_YET_RECRUITING · NA
• Erythrodiol in Pomace Olive Oil as a Protective Agent Against Atherosclerosis — NOT_YET_RECRUITING · PHASE2
• Lipoprotein (a) and Vascular Regenerative Cell Content — COMPLETED
• Randomized Comparison of Morning Versus Bedtime Administration of Statins: A Cardiovascular Circadian Chronotherapy (C3) Trial — NOT_YET_RECRUITING · PHASE4
• Effect of Icosapent-ethyl Ester (IPE) to Reduce the Residual Risk Cardiovascular Disease. — NOT_YET_RECRUITING · NA
• Variability in Human Fatty Acids Profiles Based on Blood Fractions and Metabolic Conditions — NOT_YET_RECRUITING · NA
• Social Engagement Strategies to Improve Medication Adherence — TERMINATED · NA

Refine this search